Stocktoria
vTv Therapeutics Inc. VTVT
vTv Therapeutics Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1.0M | $0 | $2.0M | $4.0M | $6.4M | $2.8M | $12.4M | $291,000 | $634,000 |
| R&D expense | $17.9M | $11.5M | $13.6M | $12.4M | $13.3M | $11.0M | $15.1M | $23.0M | $39.6M | $45.0M |
| Operating income | -$32.8M | -$24.2M | -$25.5M | -$22.5M | -$21.7M | -$11.9M | -$20.9M | -$19.8M | -$50.7M | -$55.0M |
| Interest expense | — | — | $13,000 | $15,000 | $12,000 | $692,000 | $1.8M | $3.3M | $3.1M | $398,000 |
| Income tax | $0 | $100,000 | $0 | $200,000 | $115,000 | $0 | $100,000 | $200,000 | $800,000 | $0 |
| Net income | -$27.0M | -$18.5M | -$20.2M | -$19.2M | -$13.0M | -$8.5M | -$13.0M | -$7.9M | -$16.1M | -$16.4M |
| Operating cash flow | -$25.3M | -$25.3M | -$19.1M | -$16.0M | -$19.3M | -$18.0M | -$23.0M | -$26.9M | -$44.6M | -$48.2M |
| Free cash flow | — | -$25.3M | -$19.1M | -$16.0M | -$19.3M | -$18.0M | -$23.1M | -$26.9M | -$44.6M | -$48.3M |
| Cash & equivalents | $88.9M | $36.7M | $9.4M | $12.1M | $13.4M | $5.7M | $1.8M | $1.7M | $11.8M | $51.5M |
| Total assets | $89.9M | $38.3M | $11.0M | $33.2M | $25.5M | $14.8M | $9.3M | $8.6M | $27.9M | $54.5M |
| Total liabilities | $25.5M | $24.0M | $29.6M | $27.4M | $10.3M | $11.0M | $18.1M | $28.9M | $47.5M | $22.9M |
| Shareholders' equity | $64.4M | $14.3M | -$24.7M | -$10.7M | -$9.7M | -$80.1M | -$49.0M | -$82.9M | -$151.0M | -$90.9M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -100.0% | — | -100.0% | -49.6% | -37.6% | +132.1% | -77.8% | +4172.9% | -54.1% | +22.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.